Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Daiichi Sankyo
Daiichi Sankyo
UNICANCER
Krystal Biotech, Inc.
Shenyang Sunshine Pharmaceutical Co., LTD.
Turku University Hospital
RenJi Hospital
Korea University Guro Hospital
Mabwell (Shanghai) Bioscience Co., Ltd.
Bnai Zion Medical Center
Persephone Biosciences